129 related articles for article (PubMed ID: 17355553)
21. Reversible methotrexate-associated lymphoproliferative disorder resembling advanced gastric cancer in a patient with rheumatoid arthritis.
Satoh K; Yoshida N; Imaizumi K; Yajima M; Wakui H; Sawada K; Komatsuda A
Am J Med Sci; 2009 Oct; 338(4):334-5. PubMed ID: 19745701
[TBL] [Abstract][Full Text] [Related]
22. Methotrexate osteopathy, does it exist?
Maenaut K; Westhovens R; Dequeker J
J Rheumatol; 1996 Dec; 23(12):2156-9. PubMed ID: 8970056
[TBL] [Abstract][Full Text] [Related]
23. Methotrexate-induced acute lung injury in a patient with rheumatoid arthritis.
Taniguchi K; Usui Y; Matsuda T; Suzuki S; Fujiki K; Yakusiji F; Tomiyama J; Kinoshita K; Ilzuka H; Kuga Y
Int J Clin Pharmacol Res; 2005; 25(3):101-5. PubMed ID: 16366417
[TBL] [Abstract][Full Text] [Related]
24. The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment.
Breedveld FC; Weisman MH; Kavanaugh AF; Cohen SB; Pavelka K; van Vollenhoven R; Sharp J; Perez JL; Spencer-Green GT
Arthritis Rheum; 2006 Jan; 54(1):26-37. PubMed ID: 16385520
[TBL] [Abstract][Full Text] [Related]
25. The time course of gastric methotrexate intolerance in patients with rheumatoid arthritis and psoriatic arthritis.
Dalkilic E; Sahbazlar M; Gullulu M; Yavuz M; Dilek K; Ersoy A; Ozkaya G; Yurtkuran M
Mod Rheumatol; 2013 May; 23(3):525-8. PubMed ID: 22752502
[TBL] [Abstract][Full Text] [Related]
26. Lessons for the use of non-biologic anchor treatments for rheumatoid arthritis in the era of biologic therapies.
Jacobs JW
Rheumatology (Oxford); 2012 Jun; 51 Suppl 4():iv27-33. PubMed ID: 22685273
[TBL] [Abstract][Full Text] [Related]
27. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone.
Durez P; Malghem J; Nzeusseu Toukap A; Depresseux G; Lauwerys BR; Westhovens R; Luyten FP; Corluy L; Houssiau FA; Verschueren P
Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189
[TBL] [Abstract][Full Text] [Related]
28. Neuropsychological outcome after chemotherapy for primary CNS lymphoma: a prospective study.
Fliessbach K; Helmstaedter C; Urbach H; Althaus A; Pels H; Linnebank M; Juergens A; Glasmacher A; Schmidt-Wolf IG; Klockgether T; Schlegel U
Neurology; 2005 Apr; 64(7):1184-8. PubMed ID: 15824344
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.
Lie E; van der Heijde D; Uhlig T; Heiberg MS; Koldingsnes W; Rødevand E; Kaufmann C; Mikkelsen K; Kvien TK
Ann Rheum Dis; 2010 Apr; 69(4):671-6. PubMed ID: 19740904
[TBL] [Abstract][Full Text] [Related]
30. [Effects of low dose methotrexate therapy in rheumatoid arthritis: a comparison of three different dosage regimens].
Totokawa S; Furuya T; Nakajima A; Suzuki T; Kashiwazaki S
Ryumachi; 1997 Oct; 37(5):681-7. PubMed ID: 9396370
[TBL] [Abstract][Full Text] [Related]
31. Parenteral methotrexate for the treatment of rheumatoid arthritis.
Yazici Y; Bata Y
Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():46-8. PubMed ID: 24219041
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
Müller RB; von Kempis J; Haile SR; Schiff MH
Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697
[TBL] [Abstract][Full Text] [Related]
33. Fatal pulmonary fibrosis complicating low dose methotrexate therapy for rheumatoid arthritis.
van der Veen MJ; Dekker JJ; Dinant HJ; van Soesbergen RM; Bijlsma JW
J Rheumatol; 1995 Sep; 22(9):1766-8. PubMed ID: 8523359
[TBL] [Abstract][Full Text] [Related]
34. Are switches from oral to subcutaneous methotrexate or addition of ciclosporin to methotrexate useful steps in a tight control treatment strategy for rheumatoid arthritis? A post hoc analysis of the CAMERA study.
Bakker MF; Jacobs JW; Welsing PM; van der Werf JH; Linn-Rasker SP; van der Veen MJ; Lafeber FP; Bijlsma JW;
Ann Rheum Dis; 2010 Oct; 69(10):1849-52. PubMed ID: 20511610
[TBL] [Abstract][Full Text] [Related]
35. Low dose weekly methotrexate in early pregnancy. A case series and review of the literature.
Ostensen M; Hartmann H; Salvesen K
J Rheumatol; 2000 Aug; 27(8):1872-5. PubMed ID: 10955326
[TBL] [Abstract][Full Text] [Related]
36. The effect of low dose methotrexate on bone density.
Cranney AB; McKendry RJ; Wells GA; Ooi DS; Kanigsberg ND; Kraag GR; Smith CD
J Rheumatol; 2001 Nov; 28(11):2395-9. PubMed ID: 11708409
[TBL] [Abstract][Full Text] [Related]
37. [Low dose methotrexate therapy in chronic polyarthritis--an update].
Leeb BF; Smolen JS
Acta Med Austriaca; 1996; 23(4):114-9. PubMed ID: 9036721
[TBL] [Abstract][Full Text] [Related]
38. Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients receiving long-term methotrexate therapy.
Stamp LK; O'Donnell JL; Chapman PT; Zhang M; James J; Frampton C; Barclay ML
Arthritis Rheum; 2010 Feb; 62(2):359-68. PubMed ID: 20112376
[TBL] [Abstract][Full Text] [Related]
39. A case of progressive multifocal leukoencephalopathy in a patient treated with infliximab.
Kumar D; Bouldin TW; Berger RG
Arthritis Rheum; 2010 Nov; 62(11):3191-5. PubMed ID: 20722036
[TBL] [Abstract][Full Text] [Related]
40. Disseminated necrotizing leukoencephalopathy following irradiation and methotrexate therapy for central nervous system infiltration of leukemia and lymphoma.
Sakamaki H; Onozawa Y; Yano Y; Imai K; Sasaki T; Ibuka T; Funada N; Matsuda T
Radiat Med; 1993; 11(4):146-53. PubMed ID: 8234858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
